Vaxxinity Announces Board Appointments and Establishes New Headquarters in Florida
Appointment of new directors bring diversity, balance and relevant industry expertise to Vaxxinity Establishment of…
Appointment of new directors bring diversity, balance and relevant industry expertise to Vaxxinity Establishment of…
Gardening Supplier, Hozelock, to Roll Out Hygienic and Non-Invasive Intelligent Fingerprinting for Drug Tests to…
Partnership Will Provide Pharmaceutical Grade Cannabinoid Active Ingredients to the Largest Pharmaceutical and Consumer Goods…
Acquisition of Worldwide Rights to Proleukin® Provides Immediate and Ongoing Revenue and Secures IL-2 Supply…
Achieves Record 4x Improvement in Time-To-Result to Provide Test Results in Under 1 Minute NEW YORK,…
Dr. Sharma and Mr. Olsheim bring more than 30 years of combined experience in the…
Eascra to showcase Janus Base Nanomaterials (JBNs) in the Innovation category BOSTON, Jan. 18, 2023…
Acquisition to enable creation of a fully integrated, enterprise-wide capability to discover, design and develop…
Live video webcast presentation on Tuesday, January 17th at 11:00 AM ET ISELIN, N.J., Jan….
— Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory…
Attained U.S. Food and Drug Administration (FDA) Prescription Drug User Fee Act (PDUFA) goal date…
ISELIN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”),…
NEW YORK, Dec. 22, 2022 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
Decision for potential approval expected from European Commission in early 2024 Submission follows the U.S….
New agreement supports the discovery and development of additional assets directed toward high conviction targets…
Approximately 11,500 of the companies’ mRNA-based COVID-19 vaccine doses arrived on the Chinese Mainland to…
Company Intends to Hold FY 2022 Annual Meeting in February 2023 NEW YORK, Dec. 21,…
Closing of Three Separate Transformative Capital Financings, Including Two Significant Non-Dilutive Transactions, Generates Combined Gross…
RevoluGen Announces Distribution Agreement with BioEntist for Fire Monkey HMW-DNA Extraction Products in Thailand RevoluGen’s…
6 out of 7 eligible patients with relapsed/refractory Non-Hodgkin Lymphoma (rrNHL) responded to treatment (ORR…